Technical Analysis for PRTG - Portage Biotech Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| A | 39.9 | -6.80% | -2.91 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | Up | Up |
| Historical PRTG trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bullish | Bullish Swing Setup | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| New 52 Week Closing High | Bullish | -6.80% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 3 days ago |
| New 52 Week High | 3 days ago |
| 2x Volume Pace | 3 days ago |
| 1.5x Volume Pace | 3 days ago |
| Down 5% | 3 days ago |
Get a Trading Sidekick!
- Earnings date: ???
Portage Biotech Inc. Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Immunology Solid Tumors Immune System Antibodies Interferon Biotechnology Products Acute Kidney Injury
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 44.9763 |
| 52 Week Low | 26.05 |
| Average Volume | 17,973 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 29.78 |
| 20-Day Moving Average | 32.09 |
| 10-Day Moving Average | 35.70 |
| Average True Range | 2.37 |
| ADX | 35.43 |
| +DI | 40.54 |
| -DI | 5.23 |
| Chandelier Exit (Long, 3 ATRs) | 37.86 |
| Chandelier Exit (Short, 3 ATRs) | 33.45 |
| Upper Bollinger Bands | 42.04 |
| Lower Bollinger Band | 22.13 |
| Percent B (%b) | 0.89 |
| BandWidth | 62.03 |
| MACD Line | 3.09 |
| MACD Signal Line | 1.84 |
| MACD Histogram | 1.2483 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 49.97 | ||||
| Resistance 3 (R3) | 50.55 | 47.76 | 48.30 | ||
| Resistance 2 (R2) | 47.76 | 45.20 | 47.48 | 47.74 | |
| Resistance 1 (R1) | 43.83 | 43.61 | 42.44 | 43.26 | 47.18 |
| Pivot Point | 41.05 | 41.05 | 40.35 | 40.76 | 41.05 |
| Support 1 (S1) | 37.11 | 38.48 | 35.72 | 36.54 | 32.62 |
| Support 2 (S2) | 34.33 | 36.89 | 34.04 | 32.06 | |
| Support 3 (S3) | 30.40 | 34.33 | 31.50 | ||
| Support 4 (S4) | 29.83 |
